HIGHLIGHTS
- who: Corinne Frere and colleagues from the Sorbonne Université, GRC , GRECO, Paris, France have published the paper: Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies, in the Journal: Cancers 2019, 11, 1639 of /2019/
- what: A marginally significant decrease in cancer incidence was observed only when the analysis was restricted to trials of daily aspirin use, including secondary prevention studies, and having a median intended duration of at least four years (four trials; n=11,800; RR, 0.86; 95% CI, 0.74-0.99) .
- how: This result was further attributed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.